AstraZeneca PLC (AZNCF)
OTCMKTS
· Delayed Price · Currency is USD
135.36
+7.91 (6.21%)
May 12, 2025, 4:00 PM EDT
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
$583,054
Profits / Employee
$82,418
Market Cap
209.59B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
CytoDyn | 9 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
AstraZeneca News
- 23 hours ago - AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025 - Business Wire
- 1 day ago - AstraZeneca and GSK in the firing line as Trump targets big pharma: ALEX BRUMMER - This is Money
- 2 days ago - Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices - WSJ
- 2 days ago - Pharmaceutical stocks slide as Trump vows to cut US prescription drug prices ‘by 30-80%' - The Guardian
- 2 days ago - AstraZeneca (AZN) Faces Market Uncertainty Amid Drug Pricing Changes | AZN Stock News - GuruFocus
- 4 days ago - AstraZeneca's bladder cancer treatment shows positive results in trial - Seeking Alpha
- 4 days ago - IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial - Business Wire
- 6 days ago - AstraZeneca, Daiichi post late-stage trial win for Enhertu in early-stage breast cancer - Seeking Alpha